Sort
30,917 grants matching “tumor microenvironment”
Molecular mechanisms of antibody-mediated immunotherapies
$1,017,000Jeffrey Victor Ravetch · Rockefeller University · R35 · FY2017 · CA
Molecular mechanisms of antibody-mediated immunotherapies
$1,017,000Jeffrey Victor Ravetch · Rockefeller University · R35 · FY2016 · CA
Identifying Metabolic Dependencies of Pancreatic Cancers
$1,017,000Alec Kimmelman · New York University School Of Medicine · R35 · FY2021 · CA
Molecular mechanisms of antibody-mediated immunotherapies
$1,017,000Jeffrey Victor Ravetch · Rockefeller University · R35 · FY2018 · CA
Molecular mechanisms of antibody-mediated immunotherapies
$1,017,000Jeffrey Victor Ravetch · Rockefeller University · R35 · FY2021 · CA
Molecular mechanisms of antibody-mediated immunotherapies
$1,017,000Jeffrey Victor Ravetch · Rockefeller University · R35 · FY2020 · CA
Intracellular In vivo Imaging
$1,016,705Peter L. Choyke · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Systemic regulation of metastasis
$1,016,466David Charles Lyden · Weill Medical Coll Of Cornell Univ · R35 · FY2020 · CA
Advancing Cancer Therapy through Ground Breaking Research in Radiation Biology
$1,016,247David G Kirsch · Duke University · R35 · FY2020 · CA
Integrating systems immunology with immunometabolism and cancer immunity
$1,016,190Hongbo Chi · St. Jude Children'S Research Hospital · R35 · FY2024 · CA
Targeting intratumor heterogeneity in breast cancer
$1,015,451Kornelia Polyak · Dana-Farber Cancer Inst · R35 · FY2023 · CA
Mechanism of action and therapeutic utility of immunostimulatory CpG oligonucleo
$1,015,446Dennis Klinman · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Spatial functional genomics to identify regulators of the tumor microenvironment and cancer immunity
$1,015,368Brian D Brown · Icahn School Of Medicine At Mount Sinai · U01 · FY2025 · CA
A Rational Systematic Approach to Find Combinations of Pharmacologic and Immune Therapies that Target Identifiable Oncogenic States
$1,014,721Pablo Tamayo · University Of California, San Diego · U01 · FY2018 · CA
Molecular, Cellular, and Tissue Characterization Unit
$1,014,589Dana Pe'er · Sloan-Kettering Inst Can Research · U2C · FY2018 · CA
Reprogramming of T cells for the Treatment of Melanoma
$1,014,415Kai W Wucherpfennig · Dana-Farber Cancer Inst · R01 · FY2012 · CA
Molecular diagnosis and outcome prediction in lymphoma
$1,013,664Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Molecular signatures for liver cancer diagnosis and treatment stratification
$1,013,528Xin Wang · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Induction of an Antitumor Immune Response in Patients with Melanoma
$1,013,259Patrick Hwu · University Of Tx Md Anderson Can Ctr · P50 · FY2010 · CA
Human EGFRvIII-specific BiTE for the treatment of Glioblastoma
$1,012,736John H Sampson · Duke University · U01 · FY2018 · NS
Dissecting Pediatric Brain Tumor Microenvironment to Improve Treatment
$1,012,680Rakesh K. Jain · Massachusetts General Hospital · R35 · FY2019 · CA
Elucidating the molecular and contextual basis for IDLE ultralow risk lesions and the tumor immune microenvironment of high risk in situ and invasive breast cancers
$1,012,533Laura J Esserman · University Of California, San Francisco · U01 · FY2019 · CA
A Rational Systematic Approach to Find Combinations of Pharmacologic and Immune Therapies that Target Identifiable Oncogenic States
$1,011,983Pablo Tamayo · University Of California, San Diego · U01 · FY2017 · CA
PASSCODE (Pancreatic Adenocarcinoma Stromal Reprograming ConSortium COordination, Data Management and Education)
$1,010,953Anirban Maitra · New York University School Of Medicine · U24 · FY2025 · CA
Role of inflammation, innate resistance, and immunity in carcinogenesis
$1,010,680Giorgio Trinchieri · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA